JEEVA
LIVE

Serial Number

88769614

Owner

Jeeva Informatics Solutions, Inc.

Attorney

Aaron D. Hendelman

First Use Date

Dec 21, 2020

Filing Date

Jan 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

JEEVA Trademark

Serial Number: 88769614 • Registration: 6925350

JEEVA is a trademark filed by Jeeva Informatics Solutions, Inc. on January 22, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Jeeva Informatics Solutions, Inc. (2 trademarks)

Herndon, VA 20171

Entity Type: 03

Trademark Details

Filing Date

January 22, 2020

Registration Date

December 13, 2022

First Use Anywhere

December 21, 2020

First Use in Commerce

April 14, 2022

Published for Opposition

May 26, 2020

Goods & Services

Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials; business consulting and management in the field of regulatory submission management, namely, clinical trial data integrity and immutability; database management in the field of clinical trials; updating and maintenance of data in computer databases in the field of clinical trials

Software as a service (SAAS) services featuring software for the processing and analysis of data using artificial intelligence and natural language processing; Software as a service (SAAS) services featuring software for planning, management and operational management in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software featuring machine learning technology for planning, management, operational management, and study design optimization in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software for estimating the probability of clinical trial success; Software as a service (SAAS) services featuring software featuring machine learning technology for capturing, collecting, managing, analyzing, and reporting data from clinical trials and drug discovery for use in database management and processing data; scientific consulting services in the field of conducting clinical trials for others; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial, drug development, drug discovery information; providing medical and scientific research information in the field of clinical trials; providing online searchable databases featuring medical and scientific research clinical trial information whereby users can input and collect data and information for research purposes; pharmaceutical research and development information services in the field of health care and clinical trials; Software as a service (SAAS) services featuring software for real-time and long-term patient monitoring and safety review in the field of clinical trials; Software as a service (SAAS) services featuring software for the processing and analysis of data for use in the discovery of disease biomarkers for diagnostic and therapeutic purposes; structural and functional analysis of genomes; database development services, namely, providing configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; database development services, namely, providing configuration and customization of computer databases in the field of medical information related healthcare and long-term health management; medical research, namely, compiling and analyzing genomics data for use in the discovery of disease biomarkers which are used for diagnostic and therapeutic purposes

Medical services, namely, medical advice relating to the design of clinical trials, late phase research, adverse event reporting and safety monitoring of clinical trials; medical services, namely, medical advice relating to long-term health management

Filing History

CANCELLATION INSTITUTED NO. 999999
May 29, 2026 PETC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 8, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 5, 2022 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 28, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 28, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 27, 2022 AITU
USE AMENDMENT FILED
Sep 14, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 14, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jul 8, 2022 EX4G
SOU EXTENSION 4 FILED
Jul 8, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jan 7, 2022 EX3G
SOU EXTENSION 3 FILED
Jan 7, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 7, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 5, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jun 3, 2021 EX2G
SOU EXTENSION 2 FILED
Jun 3, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 3, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 6, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 6, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 6, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 21, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
ASSIGNED TO LIE
Apr 20, 2020 ALIE
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Apr 13, 2020 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
Apr 13, 2020 LOPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2020 CNEA
ASSIGNED TO EXAMINER
Apr 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2020 NWOS
NEW APPLICATION ENTERED
Jan 25, 2020 NWAP